Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

148
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
148
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Biostatistics: Overview01:20

Biostatistics: Overview

413
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
413

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

HDDI-Net: Hierarchical dual-domain interaction network for robust and efficient ultrasound lesion segmentation.

Medical & biological engineering & computing·2026
Same journal

Nonhomogeneous smoke mitigation in laparoscopic images using a hybrid physical-neural model.

Medical & biological engineering & computing·2026
Same journal

Individualized multimodal integration of optimized dual fluoroscopic imaging registration and finite element modeling for knee joint stress during stair ascent.

Medical & biological engineering & computing·2026
Same journal

Thorax shape reconstruction from limited CT-digitized palpable landmarks using statistical shape modeling.

Medical & biological engineering & computing·2026
Same journal

A coarse-to-fine machine-learning framework for identifying functional connectivity markers of cognitive impairment in Parkinson's disease.

Medical & biological engineering & computing·2026
Same journal

Design and clinical evaluation of a virtual reality-based system for automated ocular deviation measurement.

Medical & biological engineering & computing·2026

Related Experiment Video

Updated: Oct 18, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K

Framework for classification of cancer gene expression data using Bayesian hyper-parameter optimization.

Nimrita Koul1, Sunilkumar S Manvi2

  • 1School of Computer Science and Engineering, REVA University, Bangalore, Karnataka, 560064, India. Nimrita.koul@reva.edu.in.

Medical & Biological Engineering & Computing
|October 5, 2021
PubMed
Summary

This study introduces a computational framework to classify cancer gene expression profiles, improving accuracy and reducing computation time. The novel approach effectively handles complex biological data for better cancer diagnosis.

Keywords:
Bayesian optimizationClassification frameworkEnsemble classificationHyper-parameter optimizationMicroarray cancer gene expression data

More Related Videos

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.7K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K

Related Experiment Videos

Last Updated: Oct 18, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.2K
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.7K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Cancer classification from gene expression data is challenging due to high dimensionality, limited samples, and class imbalance.
  • Existing methods often struggle with the complexity and scale of genomic datasets.

Purpose of the Study:

  • To develop and evaluate a robust computational framework for accurate cancer gene expression profile classification.
  • To enhance diagnostic efficiency by optimizing feature selection and classifier performance.

Main Methods:

  • A multi-stage pipeline involving data pre-processing (scaling, normalization), recursive feature elimination (RFE) with genetic algorithm refinement, and a diverse classifier meta-pool.
  • Hyper-parameter optimization using Bayesian Optimization and a novel algorithm for selecting the best classifier based on accuracy and computation time.

Main Results:

  • The proposed framework demonstrated significant improvements in classification accuracy and reduced computation time on multiple microarray and PAN-Cancer RNA sequencing datasets.
  • The selected classifier consistently outperformed state-of-the-art methods in predicting cancer types.

Conclusions:

  • The developed framework offers a superior approach to computational cancer classification using gene expression data.
  • This method provides a more efficient and accurate tool for cancer diagnosis and research.